Stephanie E. Areloegbe

ORCID, self-asserted

ORCID 0000-0002-0159-8089

Publications

Citations

286

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

36 works in the graph, newest first.

Mitochondrial dynamics in depression: friend or foe?
2026Metabolic Brain DiseaseJournal0 citations10.1007/s11011-026-01876-y
Butyrate ameliorates ovarian failure in experimental PCOS rat model by suppression of HDAC2
2025Comparative Clinical PathologyJournal5 citations10.1007/s00580-025-03633-6
Probiotics ameliorates hypothalamic amenorrhea in a rat model of PCOS
2025Metabolic Brain DiseaseJournalFirst authorCorresponding6 citations10.1007/s11011-025-01573-2
Carvone attenuates cardiac fibrosis and inflammation by modulating GSK-3β/PKC-α signalling pathway in experimentally induced polycystic ovarian syndrome
2025Toxicology and Applied PharmacologyJournal2 citations10.1016/j.taap.2025.117599
Suppression of adipose TGF-β1 by probiotics alleviates metabolic disturbance in experimentally induced PCOS
2025Prostaglandins & Other Lipid MediatorsJournalSenior author4 citations10.1016/j.prostaglandins.2025.106989
Renometabolic disorder in experimental rat model of polycystic ovarian syndrome is reversed by acetate-mediated inhibition of pyruvate dehydrogenase kinase 4
2025BMC NephrologyJournalOpen accessFirst author2 citations10.1186/s12882-025-04157-5
Suppression of protein kinase RNA-like endoplasmic reticulum kinase by probiotics circumvents cardiovascular risk profile in experimentally induced PCOS model
2025Canadian Journal of Physiology and PharmacologyJournalFirst author1 citations10.1139/cjpp-2025-0095
Mentha spicata and Its Bioactive Compound Carvone Ameliorate Metabolic Disturbance and Ovarian Dysfunction in Experimental Rat Model of PCOS by Suppression of SREBP1/TLR4‐Dependent Pathway
2025American Journal of Reproductive ImmunologyJournal1 citations10.1111/aji.70183
The Role of Cervicovaginal Microbiome in the Pathogenesis of Cervical Cancer
2025Indian Journal of Gynecologic OncologyJournal0 citations10.1007/s40944-025-00966-6
Acetate alleviates glucose dysregulation and atherogenic dyslipidaemia in experimentally induced PCOS
2025Babcock University Medical JournalJournalOpen accessFirst author0 citations10.38029/babcockuniv.med.j..v8i1.719
Probiotics mitigates ovarian angiogenic disturbance in letrozole-induced PCOS
2025BMC Complementary Medicine and TherapiesJournalOpen accessFirst author0 citations10.1186/s12906-025-05109-0
Acetate attenuates hypothalamic pyroptosis in experimentally induced polycystic ovarian syndrome
2024BMC Research NotesJournalOpen access11 citations10.1186/s13104-024-06921-6
Butyrate-Mediated Modulation of Paraoxonase-1 Alleviates Cardiorenometabolic Abnormalities in a Rat Model of Polycystic Ovarian Syndrome
2024Cardiovascular Drugs and TherapyJournalCorresponding6 citations10.1007/s10557-024-07649-y
Acetate ameliorates ovarian mitochondrial dysfunction in letrozole-induced polycystic ovarian syndrome rat model by improving mitofusin-2
2024The Journal of Physiological SciencesJournalOpen accessSenior author9 citations10.1186/s12576-024-00908-5
Butyrate alleviates adipose mitochondrial dysfunction and inflammation in experimental model of polycystic ovarian syndrome by modulating SIRT1-dependent mechanism
2024NutrireJournalSenior author3 citations10.1186/s41110-024-00273-8
Acetate abates adipose-ovarian endocrinometabolic disturbance in experimentally induced polycystic ovarian syndrome
2024SteroidsJournal2 citations10.1016/j.steroids.2024.109554
Modulation of PON-1 by acetate reverses hepatic dysmetabolism in experimentally induced PCOS
2024Comparative Clinical PathologyJournalSenior author1 citations10.1007/s00580-024-03553-x
Panax ginseng Ameliorates Pituitary-ovarian Dysfunction Induced by Radiofrequency Electromagnetic Radiation from Cell Phones via Upregulation of the CREM Signaling Pathway
2024Current Drug Discovery TechnologiesJournal0 citations10.2174/0115701638279386240425050818
Hepatic dysmetabolism in polycystic ovarian syndrome: impact of paraoxonase-1 modulation by butyrate
2024Comparative Clinical PathologyJournalFirst authorCorresponding0 citations10.1007/s00580-024-03580-8
Modulation of GABA by sodium butyrate ameliorates hypothalamic inflammation in experimental model of PCOS
2023BMC NeuroscienceJournalOpen access20 citations10.1186/s12868-023-00834-z
Cardiac energy depletion in a rat model of polycystic ovarian syndrome is reversed by acetate and associated with inhibitory effect of HDAC2/mTOR
2023European Journal of PharmacologyJournalOpen access10 citations10.1016/j.ejphar.2023.176243
Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome
2023Toxicology and Applied PharmacologyJournal10 citations10.1016/j.taap.2023.116604
Alleviation of adipose–hepatic glycolipid dysregulation by acetate in experimental PCOS model is associated with NF-κB/NLRP3 repression
2023Canadian Journal of Physiology and PharmacologyJournalSenior author7 citations10.1139/cjpp-2023-0169
Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1
2023Biochemical and Biophysical Research CommunicationsJournalFirst author6 citations10.1016/j.bbrc.2023.09.061
Panax ginseng supplementation protects against testicular damage induced by radiofrequency electromagnetic radiation from cell phone
2023NutrireJournalOpen access3 citations10.1186/s41110-023-00234-7
Modulatory effect of PPAR-γ by acetate on cardiorenometabolic disturbance associated with high fat diet–fed insulin-resistant male Wistar rats
2023Comparative Clinical PathologyJournal2 citations10.1007/s00580-023-03436-7
Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats
2023NutrireJournalFirst author1 citations10.1186/s41110-023-00205-y
Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model
2022PLoS ONEJournalOpen access43 citations10.1371/journal.pone.0272124
Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome
2022Life SciencesJournalSenior author32 citations10.1016/j.lfs.2022.120560
Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model
2022BMC Endocrine DisordersJournalOpen accessFirst author29 citations10.1186/s12902-022-01143-y
Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity
2022EndocrineJournal22 citations10.1007/s12020-022-03191-9
Protective Role of Acetate Against Depressive-Like Behaviour Associated with Letrozole-Induced PCOS Rat Model: Involvement of HDAC2 and DNA Methylation
2022Molecular NeurobiologyBook Chapter20 citations10.1007/s12035-022-03074-0
Acetate: A therapeutic candidate against renal disorder in a rat model of polycystic ovarian syndrome
2022The Journal of Steroid Biochemistry and Molecular BiologyJournalSenior author10 citations10.1016/j.jsbmb.2022.106179
Acetate circumvents impaired metabolic switch in skeletal muscle of letrozole-induced PCOS rat model by suppression of PDK4/NLRP3
2022NutritionJournalSenior author11 citations10.1016/j.nut.2022.111914
Low-dose spironolactone abates cardio-renal disorder by reduction of BAX/inflammasome expression in experimentally induced polycystic ovarian syndrome rat model
2022Canadian Journal of Physiology and PharmacologyJournal5 citations10.1139/cjpp-2022-0176
Mineralocorticoid receptor blockade attenuates hyperandrogenic metabolic dysregulation in letrozole-induced PCOS rat model
2022Journal of Diabetes & Metabolic DisordersJournalOpen access2 citations10.1007/s40200-022-01097-x